Gliknik
PrivateLast Round
Early Funding
Jul 7, 2023
Total Funding Raised
$67.89M
Momentum Score
50 /100
Company Overview
Gliknik is a biopharmaceutical company focused on developing innovative therapies to treat cancer and autoimmune diseases, providing drug modules that enhance the immune system to improve patient outcomes and alleviate suffering.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gliknik Comps
Public and private peers based on sector, stage, and business model.
Gliknik Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 7, 2023 | ||||
| Series C | Jun 24, 2021 | ||||
| Corporate Funding | Feb 19, 2019 | ||||
| Corporate Funding | Sep 30, 2013 | ||||
| Series B | Oct 8, 2012 | ||||
Grant | Oct 3, 2011 |
Gliknik Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| William Harris Investors | Series A |
| National Cancer Institute | Grant |
| Baxter Ventures | Series B |
| RDA Ventures | Series A, Series C |
| First In Ventures | Series C |
| LifeTech Developments Fund | Series B |
| Pfizer | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors grew 63% MoM.
Gliknik Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gliknik's valuation, stock price, and market status.
